KZA 0.00% 8.0¢ kazia therapeutics limited

KZA Media Thread, page-1289

  1. 1,135 Posts.
    lightbulb Created with Sketch. 815
    Edison Open House: Global Healthcare 2021 and will discuss the pivotal GBM AGILE study and the key upcoming milestones for Kazia in 2021.
    Dr James Garner mentions:-
    1 Patient alive more than 2 years after diagnosis with the phase 2 GBM trial.

    The paxalisib recruitment arm commenced several weeks ago for the GBM AGILE study.

    Potentially best in class toxicity for PI3K pathway.

    During 2021 Kazia will focus on commercialization.

    https://www.lsegissuerservices.com/spark/Kazia/events/4b08bd3c-338a-4a2e-b5c6-d5b0a94b5ea9

    Regards

 
watchlist Created with Sketch. Add KZA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.